Overview

Phase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy Adults

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The focus of the study is to evaluate the safety of multiple study drug administrations and the study drug selectively reducing or eliminating a specific bacteria in the mouth. It will compare a liquid and gel product applied in different modes.
Phase:
Phase 2
Details
Lead Sponsor:
Armata Pharmaceuticals, Inc.
C3 Jian, Inc.